Unveiling Circulating Targets in Pancreatic Cancer: Insights from Proteogenomic Evidence and Clinical Cohorts
Authors:
Preprint
Abstract
Pancreatic cancer (PC), lacking biomarkers and effective therapeutics, remains highly lethal. Data regarding the correlations of PC risk and the individual plasma proteome known for minimally cancer biomarkers, are scarce. Here, we measure 1,345 human plasma proteins via Proteome-Wide Association Studies, presenting 78 proteins are prominently related to PC risk, including 4 proteins (ROR1, FN1, APOA5, ABO) exhibit the strongest causal association identified via Mendelian Randomization and Colocalization. Our two independent cohorts further demonstrate FN1 and ABO are highly expressed in blood or tumors from patients with PC compared to specimens from healthy individuals or para-tumors. Moreover, patients with higher levels of FN1 and ABO in their blood or tumors have worse median survival than those with lower levels. Multiple drugs targeting FN1 are currently available or undergoing clinical testing, making FN1 a promisingly repurposed therapeutic target in addition to severing as a circulating prognostic indicator for PC.Keywords
All Related Versions
- Published version: iScience, 28 (3), 111693.
This publication has 63 references indexed in Scilit:
- ABO Blood Group and Risk of Pancreatic Cancer: A Study in Shanghai and Meta-AnalysisAmerican Journal of Epidemiology, 2013
- A Dose-Escalation and Signal-Generating Study of the Immunocytokine L19-IL2 in Combination with Dacarbazine for the Therapy of Patients with Metastatic MelanomaClinical Cancer Research, 2011
- On the Development of Plasma Protein BiomarkersJournal of Proteome Research, 2011
- The tumour-targeting human L19-IL2 immunocytokine: Preclinical safety studies, phase I clinical trial in patients with solid tumours and expansion into patients with advanced renal cell carcinomaEuropean Journal of Cancer, 2010
- METAL: fast and efficient meta-analysis of genomewide association scansBioinformatics, 2010
- Genome-Wide Association Studies: Contribution of Genomics to Understanding Blood Pressure and Essential HypertensionCurrent Hypertension Reports, 2010
- Genome-wide association study identifies variants in the ABO locus associated with susceptibility to pancreatic cancerNature Genetics, 2009
- Expression of the oncofetal ED-B–containing fibronectin isoform in hematologic tumors enables ED-B–targeted 131I-L19SIP radioimmunotherapy in Hodgkin lymphoma patientsBlood, 2009
- The Targeted Immunocytokine L19-IL2 Efficiently Inhibits the Growth of Orthotopic Pancreatic CancerClinical Cancer Research, 2008
- Molecular genetic basis of the histo-blood group ABO systemNature, 1990